Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,574.64
(
0.15%
)
US TECH 100
29,476.02
(
0.18%
)
Dow Jones
50,955.32
(
0.57%
)
Brent Oil
91.45
(
-0.79%
)
Bitcoin
73,655.97
(
0.16%
)
News Focus
News Focus

Replies to post #4831 on TransCode Therapeutics Inc (RNAZ)

Replies to #4831 on TransCode Therapeutics Inc (RNAZ)
icon url

MartinLutherKing

10/12/24 7:52 PM

#4832 RE: zj3001 #4831

Spread the love, spread the wild fire worldwide,
icon url

MartinLutherKing

10/12/24 9:54 PM

#4839 RE: zj3001 #4831

TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of other first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.